J Nutr 2016. Effect of Ultraviolet Light-Exposed Mushrooms on Vitamin D Status: LC-MS/MS Reanalysis of Biobanked Sera from an RCT and a Systematic Review plus Meta-Analysis (PMID 26865648).
Rationale
The RCT data on UV mushrooms and 25(OH)D were "limited and mixed". The authors pooled all eligible RCTs and added their own LC-MS/MS reanalysis of sera — the gold standard for vitamin-D metabolites instead of the less accurate immunoassay.
Methods
- Systematic search of Ovid MEDLINE, EMBASE, Cochrane CENTRAL → 6 RCTs of UV-exposed mushrooms reporting serum 25(OH)D.
- Reanalysis of biobanked sera from one RCT by LC-MS/MS for separate 25(OH)D2 and 25(OH)D3.
- Meta-analysis using weighted mean difference (WMD).
Results
- Across all 6 RCTs: 25(OH)D did not rise significantly (P=0.12), with high heterogeneity (I²=87%).
- 3 European RCTs (baseline ~38.6 nmol/L — deficiency): +15.2 nmol/L gain, significant (P=0.03).
- 3 US RCTs (baseline ~81.5 nmol/L — adequate): no effect (P=0.83).
- By vitamin form: UV mushrooms raise 25(OH)D2 but lower 25(OH)D3 — displacement confirmed.
Conclusions
UV-treated mushrooms improve vitamin D status only where it was low (European populations with deficiency); with adequate baseline there is no effect. The heterogeneity is explained precisely by differing baseline status and geography.
Caveats
- The key framing for readers: "mushroom vitamin D" is a tool against deficiency, not a universal supplement. Expecting a boost where none is missing is futile.
- The D2→D3 displacement shows why total 25(OH)D is the right endpoint, not 25(OH)D2 alone.
- High heterogeneity (I²=87–88%) is an honest signal: real doses, mushroom species and UV protocols differed between trials; "any UV mushrooms" is too broad a category.
- The LC-MS/MS reanalysis showed immunoassays can distort separate D2/D3 accounting — a methodological detail that matters when reading older RCTs.